A board to discuss future MS therapies in early stage (Phase I or II) trials.
The CLARITY Study is a double-blind clinical trial of an oral form (tablet) of the investigational medicine Cladribine. Certain forms of Cladribine are approved for use in other illnesses, but research is still needed on treating multiple sclerosis with Cladribine tablets.
The study is testing a Cladribine tablet against a placebo tablet (an inactive look-alike tablet). Some questions researchers hope to answer are:
Does this study drug decrease the number of relapses?
Does this study drug decrease the number of MRI lesions?
Is the study drug safe, as well as effective?
The purpose of the CLARITY study is to evaluate the safety and effectiveness of Cladribine tablets. Researchers are testing two different doses of Cladribine tablets against placebo.
All participants in the study will be given either Cladribine tablets or placebo tablets. The chance of getting Cladribine tablets is 2 out of 3.
I am what I am
- Family Elder
- Posts: 288
- Joined: Sun Jul 11, 2004 3:00 pm
- Location: England
Return to Drug Pipeline
- New trial of MBP8298 for RRMS
by dignan » Thu Nov 23, 2006 3:25 pm
- 3 Replies
- 1222 Views
- Last post by Melody
Fri Nov 24, 2006 7:27 pm
- MBP8298 trial for RRMS
by dignan » Thu May 03, 2007 8:19 am
- 0 Replies
- 1172 Views
- Last post by dignan
Thu May 03, 2007 8:19 am
- RTL-1000 phase-I recruiting
by Frank » Tue Jan 22, 2008 11:52 am
- 2 Replies
- 2560 Views
- Last post by rlawson55
Thu Sep 27, 2012 1:19 am
- MBP8298 For RRMS
by Dunmann » Mon Mar 13, 2006 9:54 am
- 1 Replies
- 1351 Views
- Last post by bromley
Wed Mar 15, 2006 1:57 pm
- MBP8298 no use for RRMS
by bromley » Fri Jan 30, 2009 8:50 am
- 1 Replies
- 1238 Views
- Last post by Hub
Fri Jan 30, 2009 9:06 am
Who is online
Users browsing this forum: No registered users